nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronabinol—ABCG2—Teniposide—lymphatic system cancer	0.187	0.222	CbGbCtD
Dronabinol—ABCG2—Mitoxantrone—lymphatic system cancer	0.13	0.155	CbGbCtD
Dronabinol—ABCG2—Vincristine—lymphatic system cancer	0.0898	0.107	CbGbCtD
Dronabinol—CYP2C19—Teniposide—lymphatic system cancer	0.0834	0.099	CbGbCtD
Dronabinol—CYP2C9—Teniposide—lymphatic system cancer	0.0693	0.0823	CbGbCtD
Dronabinol—ABCG2—Methotrexate—lymphatic system cancer	0.0544	0.0646	CbGbCtD
Dronabinol—ABCB1—Mitoxantrone—lymphatic system cancer	0.047	0.0559	CbGbCtD
Dronabinol—CYP3A4—Cytarabine—lymphatic system cancer	0.0409	0.0486	CbGbCtD
Dronabinol—CYP3A4—Teniposide—lymphatic system cancer	0.0403	0.0479	CbGbCtD
Dronabinol—ABCB1—Vincristine—lymphatic system cancer	0.0324	0.0385	CbGbCtD
Dronabinol—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0282	0.0335	CbGbCtD
Dronabinol—ABCB1—Methotrexate—lymphatic system cancer	0.0196	0.0233	CbGbCtD
Dronabinol—CYP3A4—Vincristine—lymphatic system cancer	0.0194	0.023	CbGbCtD
Dronabinol—Paranoid reaction—Carmustine—lymphatic system cancer	0.00451	0.0285	CcSEcCtD
Dronabinol—Speech impairment NOS—Methotrexate—lymphatic system cancer	0.00407	0.0257	CcSEcCtD
Dronabinol—Faecal incontinence—Carmustine—lymphatic system cancer	0.0038	0.024	CcSEcCtD
Dronabinol—Paranoia—Carmustine—lymphatic system cancer	0.00281	0.0177	CcSEcCtD
Dronabinol—Depression—Mechlorethamine—lymphatic system cancer	0.00258	0.0163	CcSEcCtD
Dronabinol—Speech disorder—Carmustine—lymphatic system cancer	0.00223	0.0141	CcSEcCtD
Dronabinol—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00216	0.0137	CcSEcCtD
Dronabinol—Thinking abnormal—Carmustine—lymphatic system cancer	0.00209	0.0132	CcSEcCtD
Dronabinol—Sweating—Teniposide—lymphatic system cancer	0.00183	0.0115	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00171	0.0108	CcSEcCtD
Dronabinol—Mental disability—Carmustine—lymphatic system cancer	0.00166	0.0105	CcSEcCtD
Dronabinol—Skin disorder—Mechlorethamine—lymphatic system cancer	0.0016	0.0101	CcSEcCtD
Dronabinol—Flushing—Teniposide—lymphatic system cancer	0.00159	0.01	CcSEcCtD
Dronabinol—Anorexia—Mechlorethamine—lymphatic system cancer	0.00157	0.00992	CcSEcCtD
Dronabinol—Sinusitis—Fludarabine—lymphatic system cancer	0.00157	0.00992	CcSEcCtD
Dronabinol—Chills—Teniposide—lymphatic system cancer	0.00154	0.00969	CcSEcCtD
Dronabinol—Amnesia—Carmustine—lymphatic system cancer	0.00148	0.00935	CcSEcCtD
Dronabinol—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00143	0.00905	CcSEcCtD
Dronabinol—Chills—Fludarabine—lymphatic system cancer	0.00135	0.00852	CcSEcCtD
Dronabinol—Ataxia—Carmustine—lymphatic system cancer	0.00131	0.00826	CcSEcCtD
Dronabinol—Ataxia—Vincristine—lymphatic system cancer	0.00125	0.00788	CcSEcCtD
Dronabinol—Confusional state—Teniposide—lymphatic system cancer	0.00123	0.00774	CcSEcCtD
Dronabinol—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00122	0.00767	CcSEcCtD
Dronabinol—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00121	0.00767	CcSEcCtD
Dronabinol—Tachycardia—Teniposide—lymphatic system cancer	0.00119	0.00749	CcSEcCtD
Dronabinol—Malaise—Fludarabine—lymphatic system cancer	0.00118	0.00745	CcSEcCtD
Dronabinol—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00118	0.00742	CcSEcCtD
Dronabinol—Pruritus—Mechlorethamine—lymphatic system cancer	0.00117	0.00736	CcSEcCtD
Dronabinol—Anorexia—Teniposide—lymphatic system cancer	0.00116	0.00731	CcSEcCtD
Dronabinol—Cough—Fludarabine—lymphatic system cancer	0.00114	0.00721	CcSEcCtD
Dronabinol—Hypotension—Teniposide—lymphatic system cancer	0.00114	0.00717	CcSEcCtD
Dronabinol—Convulsion—Fludarabine—lymphatic system cancer	0.00113	0.00716	CcSEcCtD
Dronabinol—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00113	0.00712	CcSEcCtD
Dronabinol—Myalgia—Fludarabine—lymphatic system cancer	0.00111	0.00703	CcSEcCtD
Dronabinol—Discomfort—Fludarabine—lymphatic system cancer	0.0011	0.00695	CcSEcCtD
Dronabinol—Confusional state—Fludarabine—lymphatic system cancer	0.00108	0.0068	CcSEcCtD
Dronabinol—Depression—Carmustine—lymphatic system cancer	0.00107	0.00675	CcSEcCtD
Dronabinol—Decreased appetite—Teniposide—lymphatic system cancer	0.00106	0.00667	CcSEcCtD
Dronabinol—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00105	0.00661	CcSEcCtD
Dronabinol—Rash—Mechlorethamine—lymphatic system cancer	0.00104	0.00656	CcSEcCtD
Dronabinol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00104	0.00656	CcSEcCtD
Dronabinol—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00103	0.00652	CcSEcCtD
Dronabinol—Speech disorder—Methotrexate—lymphatic system cancer	0.00103	0.00651	CcSEcCtD
Dronabinol—Flushing—Bleomycin—lymphatic system cancer	0.00102	0.00646	CcSEcCtD
Dronabinol—Depression—Vincristine—lymphatic system cancer	0.00102	0.00644	CcSEcCtD
Dronabinol—Anorexia—Fludarabine—lymphatic system cancer	0.00102	0.00643	CcSEcCtD
Dronabinol—Feeling abnormal—Teniposide—lymphatic system cancer	0.001	0.00632	CcSEcCtD
Dronabinol—Drowsiness—Mitoxantrone—lymphatic system cancer	0.000997	0.00629	CcSEcCtD
Dronabinol—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000994	0.00627	CcSEcCtD
Dronabinol—Chills—Bleomycin—lymphatic system cancer	0.00099	0.00624	CcSEcCtD
Dronabinol—Sweating—Vincristine—lymphatic system cancer	0.000981	0.00619	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000974	0.00614	CcSEcCtD
Dronabinol—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.000969	0.00612	CcSEcCtD
Dronabinol—Abdominal pain—Teniposide—lymphatic system cancer	0.000961	0.00607	CcSEcCtD
Dronabinol—Hallucination—Carmustine—lymphatic system cancer	0.000958	0.00604	CcSEcCtD
Dronabinol—Sweating—Mitoxantrone—lymphatic system cancer	0.000956	0.00603	CcSEcCtD
Dronabinol—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000935	0.0059	CcSEcCtD
Dronabinol—Decreased appetite—Fludarabine—lymphatic system cancer	0.000929	0.00586	CcSEcCtD
Dronabinol—Fatigue—Fludarabine—lymphatic system cancer	0.000921	0.00581	CcSEcCtD
Dronabinol—Hallucination—Vincristine—lymphatic system cancer	0.000914	0.00577	CcSEcCtD
Dronabinol—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000897	0.00566	CcSEcCtD
Dronabinol—Hypersensitivity—Teniposide—lymphatic system cancer	0.000896	0.00565	CcSEcCtD
Dronabinol—Flushing—Carmustine—lymphatic system cancer	0.000893	0.00564	CcSEcCtD
Dronabinol—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000891	0.00562	CcSEcCtD
Dronabinol—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000881	0.00556	CcSEcCtD
Dronabinol—Asthenia—Teniposide—lymphatic system cancer	0.000872	0.00551	CcSEcCtD
Dronabinol—Malaise—Bleomycin—lymphatic system cancer	0.000866	0.00546	CcSEcCtD
Dronabinol—Pruritus—Teniposide—lymphatic system cancer	0.00086	0.00543	CcSEcCtD
Dronabinol—Cough—Bleomycin—lymphatic system cancer	0.000838	0.00529	CcSEcCtD
Dronabinol—Diarrhoea—Teniposide—lymphatic system cancer	0.000832	0.00525	CcSEcCtD
Dronabinol—Myalgia—Bleomycin—lymphatic system cancer	0.000817	0.00516	CcSEcCtD
Dronabinol—Discomfort—Bleomycin—lymphatic system cancer	0.000808	0.0051	CcSEcCtD
Dronabinol—Chills—Mitoxantrone—lymphatic system cancer	0.000803	0.00507	CcSEcCtD
Dronabinol—Confusional state—Bleomycin—lymphatic system cancer	0.00079	0.00499	CcSEcCtD
Dronabinol—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000787	0.00497	CcSEcCtD
Dronabinol—Asthenia—Fludarabine—lymphatic system cancer	0.000767	0.00484	CcSEcCtD
Dronabinol—Rash—Teniposide—lymphatic system cancer	0.000767	0.00484	CcSEcCtD
Dronabinol—Dermatitis—Teniposide—lymphatic system cancer	0.000766	0.00483	CcSEcCtD
Dronabinol—Headache—Teniposide—lymphatic system cancer	0.000762	0.00481	CcSEcCtD
Dronabinol—Pruritus—Fludarabine—lymphatic system cancer	0.000756	0.00477	CcSEcCtD
Dronabinol—Anorexia—Bleomycin—lymphatic system cancer	0.000747	0.00471	CcSEcCtD
Dronabinol—Hypotension—Bleomycin—lymphatic system cancer	0.000732	0.00462	CcSEcCtD
Dronabinol—Diarrhoea—Fludarabine—lymphatic system cancer	0.000731	0.00461	CcSEcCtD
Dronabinol—Convulsion—Carmustine—lymphatic system cancer	0.000726	0.00458	CcSEcCtD
Dronabinol—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000723	0.00456	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000714	0.0045	CcSEcCtD
Dronabinol—Myalgia—Carmustine—lymphatic system cancer	0.000713	0.0045	CcSEcCtD
Dronabinol—Anxiety—Carmustine—lymphatic system cancer	0.000711	0.00449	CcSEcCtD
Dronabinol—Malaise—Mitoxantrone—lymphatic system cancer	0.000703	0.00443	CcSEcCtD
Dronabinol—Convulsion—Vincristine—lymphatic system cancer	0.000693	0.00437	CcSEcCtD
Dronabinol—Confusional state—Carmustine—lymphatic system cancer	0.00069	0.00435	CcSEcCtD
Dronabinol—Decreased appetite—Bleomycin—lymphatic system cancer	0.000681	0.0043	CcSEcCtD
Dronabinol—Myalgia—Vincristine—lymphatic system cancer	0.000681	0.0043	CcSEcCtD
Dronabinol—Cough—Mitoxantrone—lymphatic system cancer	0.00068	0.00429	CcSEcCtD
Dronabinol—Convulsion—Mitoxantrone—lymphatic system cancer	0.000675	0.00426	CcSEcCtD
Dronabinol—Rash—Fludarabine—lymphatic system cancer	0.000674	0.00425	CcSEcCtD
Dronabinol—Dermatitis—Fludarabine—lymphatic system cancer	0.000673	0.00425	CcSEcCtD
Dronabinol—Headache—Fludarabine—lymphatic system cancer	0.000669	0.00422	CcSEcCtD
Dronabinol—Tachycardia—Carmustine—lymphatic system cancer	0.000668	0.00421	CcSEcCtD
Dronabinol—Myalgia—Mitoxantrone—lymphatic system cancer	0.000663	0.00419	CcSEcCtD
Dronabinol—Anxiety—Mitoxantrone—lymphatic system cancer	0.000661	0.00417	CcSEcCtD
Dronabinol—Discomfort—Mitoxantrone—lymphatic system cancer	0.000655	0.00414	CcSEcCtD
Dronabinol—Anorexia—Carmustine—lymphatic system cancer	0.000652	0.00411	CcSEcCtD
Dronabinol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000646	0.00407	CcSEcCtD
Dronabinol—Confusional state—Mitoxantrone—lymphatic system cancer	0.000641	0.00405	CcSEcCtD
Dronabinol—Nervous system disorder—Vincristine—lymphatic system cancer	0.00064	0.00404	CcSEcCtD
Dronabinol—Hypotension—Carmustine—lymphatic system cancer	0.000639	0.00403	CcSEcCtD
Dronabinol—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000631	0.00398	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000623	0.00393	CcSEcCtD
Dronabinol—Anorexia—Vincristine—lymphatic system cancer	0.000622	0.00393	CcSEcCtD
Dronabinol—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000621	0.00392	CcSEcCtD
Dronabinol—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000618	0.0039	CcSEcCtD
Dronabinol—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000615	0.00388	CcSEcCtD
Dronabinol—Hypotension—Vincristine—lymphatic system cancer	0.00061	0.00385	CcSEcCtD
Dronabinol—Somnolence—Carmustine—lymphatic system cancer	0.000608	0.00384	CcSEcCtD
Dronabinol—Anorexia—Mitoxantrone—lymphatic system cancer	0.000606	0.00382	CcSEcCtD
Dronabinol—Ataxia—Methotrexate—lymphatic system cancer	0.000606	0.00382	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000595	0.00375	CcSEcCtD
Dronabinol—Decreased appetite—Carmustine—lymphatic system cancer	0.000595	0.00375	CcSEcCtD
Dronabinol—Hypotension—Mitoxantrone—lymphatic system cancer	0.000594	0.00375	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000579	0.00366	CcSEcCtD
Dronabinol—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000577	0.00364	CcSEcCtD
Dronabinol—Decreased appetite—Vincristine—lymphatic system cancer	0.000568	0.00358	CcSEcCtD
Dronabinol—Somnolence—Mitoxantrone—lymphatic system cancer	0.000565	0.00357	CcSEcCtD
Dronabinol—Feeling abnormal—Carmustine—lymphatic system cancer	0.000564	0.00356	CcSEcCtD
Dronabinol—Fatigue—Vincristine—lymphatic system cancer	0.000563	0.00355	CcSEcCtD
Dronabinol—Asthenia—Bleomycin—lymphatic system cancer	0.000562	0.00355	CcSEcCtD
Dronabinol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000559	0.00353	CcSEcCtD
Dronabinol—Pruritus—Bleomycin—lymphatic system cancer	0.000554	0.0035	CcSEcCtD
Dronabinol—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000553	0.00349	CcSEcCtD
Dronabinol—Fatigue—Mitoxantrone—lymphatic system cancer	0.000548	0.00346	CcSEcCtD
Dronabinol—Abdominal pain—Carmustine—lymphatic system cancer	0.000541	0.00341	CcSEcCtD
Dronabinol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000534	0.00337	CcSEcCtD
Dronabinol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000524	0.00331	CcSEcCtD
Dronabinol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00052	0.00328	CcSEcCtD
Dronabinol—Abdominal pain—Vincristine—lymphatic system cancer	0.000516	0.00326	CcSEcCtD
Dronabinol—Hypersensitivity—Carmustine—lymphatic system cancer	0.000504	0.00318	CcSEcCtD
Dronabinol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000503	0.00317	CcSEcCtD
Dronabinol—Drowsiness—Methotrexate—lymphatic system cancer	0.000497	0.00313	CcSEcCtD
Dronabinol—Depression—Methotrexate—lymphatic system cancer	0.000495	0.00313	CcSEcCtD
Dronabinol—Rash—Bleomycin—lymphatic system cancer	0.000494	0.00312	CcSEcCtD
Dronabinol—Dermatitis—Bleomycin—lymphatic system cancer	0.000494	0.00311	CcSEcCtD
Dronabinol—Asthenia—Carmustine—lymphatic system cancer	0.000491	0.0031	CcSEcCtD
Dronabinol—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000483	0.00305	CcSEcCtD
Dronabinol—Hypersensitivity—Vincristine—lymphatic system cancer	0.000481	0.00304	CcSEcCtD
Dronabinol—Sweating—Methotrexate—lymphatic system cancer	0.000476	0.003	CcSEcCtD
Dronabinol—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000468	0.00296	CcSEcCtD
Dronabinol—Asthenia—Vincristine—lymphatic system cancer	0.000468	0.00296	CcSEcCtD
Dronabinol—Diarrhoea—Carmustine—lymphatic system cancer	0.000468	0.00295	CcSEcCtD
Dronabinol—Asthenia—Mitoxantrone—lymphatic system cancer	0.000456	0.00288	CcSEcCtD
Dronabinol—Dizziness—Carmustine—lymphatic system cancer	0.000452	0.00285	CcSEcCtD
Dronabinol—Diarrhoea—Vincristine—lymphatic system cancer	0.000447	0.00282	CcSEcCtD
Dronabinol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000435	0.00275	CcSEcCtD
Dronabinol—Dizziness—Vincristine—lymphatic system cancer	0.000432	0.00272	CcSEcCtD
Dronabinol—Rash—Carmustine—lymphatic system cancer	0.000431	0.00272	CcSEcCtD
Dronabinol—Dermatitis—Carmustine—lymphatic system cancer	0.000431	0.00272	CcSEcCtD
Dronabinol—Headache—Carmustine—lymphatic system cancer	0.000428	0.0027	CcSEcCtD
Dronabinol—Tinnitus—Methotrexate—lymphatic system cancer	0.000416	0.00262	CcSEcCtD
Dronabinol—Rash—Vincristine—lymphatic system cancer	0.000412	0.0026	CcSEcCtD
Dronabinol—Dermatitis—Vincristine—lymphatic system cancer	0.000411	0.0026	CcSEcCtD
Dronabinol—Headache—Vincristine—lymphatic system cancer	0.000409	0.00258	CcSEcCtD
Dronabinol—Immune system disorder—Methotrexate—lymphatic system cancer	0.000403	0.00254	CcSEcCtD
Dronabinol—Rash—Mitoxantrone—lymphatic system cancer	0.000401	0.00253	CcSEcCtD
Dronabinol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000401	0.00253	CcSEcCtD
Dronabinol—Chills—Methotrexate—lymphatic system cancer	0.0004	0.00252	CcSEcCtD
Dronabinol—Headache—Mitoxantrone—lymphatic system cancer	0.000398	0.00251	CcSEcCtD
Dronabinol—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00036	0.00227	CcSEcCtD
Dronabinol—Malaise—Methotrexate—lymphatic system cancer	0.00035	0.00221	CcSEcCtD
Dronabinol—Cough—Methotrexate—lymphatic system cancer	0.000339	0.00214	CcSEcCtD
Dronabinol—Convulsion—Methotrexate—lymphatic system cancer	0.000336	0.00212	CcSEcCtD
Dronabinol—Myalgia—Methotrexate—lymphatic system cancer	0.00033	0.00209	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000328	0.00207	CcSEcCtD
Dronabinol—Discomfort—Methotrexate—lymphatic system cancer	0.000327	0.00206	CcSEcCtD
Dronabinol—Confusional state—Methotrexate—lymphatic system cancer	0.000319	0.00202	CcSEcCtD
Dronabinol—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000311	0.00196	CcSEcCtD
Dronabinol—Skin disorder—Methotrexate—lymphatic system cancer	0.000308	0.00194	CcSEcCtD
Dronabinol—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000306	0.00193	CcSEcCtD
Dronabinol—Anorexia—Methotrexate—lymphatic system cancer	0.000302	0.00191	CcSEcCtD
Dronabinol—Hypotension—Methotrexate—lymphatic system cancer	0.000296	0.00187	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000289	0.00182	CcSEcCtD
Dronabinol—Somnolence—Methotrexate—lymphatic system cancer	0.000282	0.00178	CcSEcCtD
Dronabinol—Decreased appetite—Methotrexate—lymphatic system cancer	0.000275	0.00174	CcSEcCtD
Dronabinol—Fatigue—Methotrexate—lymphatic system cancer	0.000273	0.00172	CcSEcCtD
Dronabinol—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000261	0.00165	CcSEcCtD
Dronabinol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000259	0.00163	CcSEcCtD
Dronabinol—Abdominal pain—Methotrexate—lymphatic system cancer	0.00025	0.00158	CcSEcCtD
Dronabinol—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000233	0.00147	CcSEcCtD
Dronabinol—Asthenia—Methotrexate—lymphatic system cancer	0.000227	0.00143	CcSEcCtD
Dronabinol—Pruritus—Methotrexate—lymphatic system cancer	0.000224	0.00141	CcSEcCtD
Dronabinol—Diarrhoea—Methotrexate—lymphatic system cancer	0.000217	0.00137	CcSEcCtD
Dronabinol—Dizziness—Methotrexate—lymphatic system cancer	0.000209	0.00132	CcSEcCtD
Dronabinol—Rash—Methotrexate—lymphatic system cancer	0.0002	0.00126	CcSEcCtD
Dronabinol—Dermatitis—Methotrexate—lymphatic system cancer	0.0002	0.00126	CcSEcCtD
Dronabinol—Headache—Methotrexate—lymphatic system cancer	0.000198	0.00125	CcSEcCtD
